Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.8178
-0.0322-3.79%
Last update: Jun 16, 1:49 PM
Fractyl Health Inc Analyst Ratings
GUTSNASDAQ
Fractyl Health Analyst Ratings and Price Targets | NASDAQ:GUTS | Benzinga
Fractyl Health Inc has a consensus price target of $6.72 based on the ratings of 6 analysts. The high is $12 issued by Canaccord Genuity on April 15, 2025. The low is $2 issued by Morgan Stanley on January 30, 2026. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Canaccord Genuity on June 4, 2026, April 24, 2026, and March 26, 2026, respectively. With an average price target of $8 between HC Wainwright & Co., HC Wainwright & Co., and Canaccord Genuity, there's an implied 878.24% upside for Fractyl Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Canaccord Genuity
Morgan Stanley
Ladenburg Thalmann
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for Fractyl Health
Loading calendar...
FAQ
What is the target price for Fractyl Health (GUTS) stock?
The latest price target for Fractyl Health (NASDAQ:GUTS) was reported by HC Wainwright & Co. on June 4, 2026. The analyst firm set a price target for $8.00 expecting GUTS to rise to within 12 months (a possible 878.24% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fractyl Health (GUTS)?
The latest analyst rating for Fractyl Health (NASDAQ:GUTS) was provided by HC Wainwright & Co., and Fractyl Health reiterated their buy rating.
When was the last upgrade for Fractyl Health (GUTS)?
There is no last upgrade for Fractyl Health
When was the last downgrade for Fractyl Health (GUTS)?
The last downgrade for Fractyl Health Inc happened on January 30, 2026 when Morgan Stanley changed their price target from $8 to $2 for Fractyl Health Inc.
When is the next analyst rating going to be posted or updated for Fractyl Health (GUTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fractyl Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fractyl Health was filed on June 4, 2026 so you should expect the next rating to be made available sometime around June 4, 2027.
Is the Analyst Rating Fractyl Health (GUTS) correct?
While ratings are subjective and will change, the latest Fractyl Health (GUTS) rating was a reiterated with a price target of $8.00 to $8.00. The current price Fractyl Health (GUTS) is trading at is $0.82, which is out of the analyst’s predicted range.
